Goldfield Corporation

GV

TORONTO, Oct. 17, 2025 /PRNewswire/ -- Visionary Holdings Inc. (Nasdaq: GV, hereinafter referred to as "Visionary" or the "Company"), a Nasdaq-listed enterprise, announced today that it has completed the equity adjustment of "Sikang (Guangzhou) Health Industry Investment Co., Ltd." (hereinafter referred to as the "Joint Venture Company"), a joint venture established with Guangzhou Sikang Investment Holding Co., Ltd.

TORONTO , Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Holdings (Asia) Limited, has entered into a Global Product and Technology Licensing Agreement with Jiangsu Yike Regenerative Medicine Co., Ltd. ("Yike"). The agreement grants GV the worldwide rights to apply Yike's breakthrough stem cell technology, which has demonstrated significant potential in advancing treatments for diabetes and with other regenerative medicine innovations.

TORONTO , Oct. 8, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), is pleased to announce it has mailed a Notice of Meeting and Management Information Circular to Shareholders of record as of September 12, 2025 in connection with the Annual Meeting of Shareholders of the Company to be held on Wednesday, October 29, 2025, at 10:00 a.m. (Eastern Time).

HONG KONG , Sept. 24, 2025 /PRNewswire/ -- Visionary Holdings (Asia) Limited, a wholly owned subsidiary of Visionary Holdings Inc. (Nasdaq: GV), today announced the signing of a strategic cooperation agreement with Qianxin Bocheng (Jiangsu) Technology Development Co., Ltd.

NEW YORK CITY, NY / ACCESS Newswire / September 17, 2025 / Visionary Holdings Inc. (NASDAQ:GV) ("GV" or the "Company"), a technology-driven multinational enterprise, today announced that it has entered into a strategic partnership with Jiangsu Yike Regenerative Medicine. ("Yike "), a leading regenerative medical research institute in China.

TORONTO , June 5, 2025 /PRNewswire/ -- On May 21, 2025, Visionary Health Technology Group Limited, a holding subsidiary of Visionary Holdings (Nasdaq: GV), was officially established in Hong Kong. This move marks a significant step in Visionary Holdings' strategic deployment in the fields of HealthTech and the greater health industry.

TORONTO , May 27, 2025 /PRNewswire/ -- On May 23, 2025, Changle Shuang, a subsidiary of Visionary Holdings (Nasdaq: GV), officially reached a strategic partnership with the Guangzhou Jianjia Charity Foundation in Guangzhou. The two parties signed a strategic cooperation agreement around the "Healthy Stomach Future, Early Screening for Peace of Mind" national free Helicobacter pylori (Hp) screening campaign, planning to provide free Hp testing services for 10 million users to safeguard national gastrointestinal health with practical actions.

TORONTO , April 9, 2025 /PRNewswire/ --  To All Employees, Partners, and Customers: Due to a recent malicious IT attack on our company, our original official website, www.visiongroupca.com, and the corporate email suffix @farvision.ca have both been hacked. As a result, the system functions have completely broken down, and there are potential risks to data security.

TORONTO , April 9, 2025 /PRNewswire/ -- Recently, Visionary Holdings (Nasdaq: GV) successfully completed a major strategic adjustment. Through the convening of a special general meeting of shareholders and board of directors meetings, the company comprehensively optimized its corporate governance structure and future business development, laying a solid foundation for future growth.

TORONTO , March 26, 2025 /PRNewswire/ -- Recently, Visionary Holdings (Nasdaq: GV) announced the establishment of Visionary Industrial Development LPF in Hong Kong. The fund is designed to support the company's high - tech strategic development and industrial layout, especially to offer robust financial supply chain support for the new energy vehicle industry.